Literature DB >> 30066830

Ultrashortwave radiation promotes the recovery of spinal cord injury by inhibiting inflammation via suppression of the MK2/TNF‑α pathway.

Nan Wang1, Zhiping Feng1, Wei Zhao2, Zhiqiang Zhang1, Lixin Zhang1.   

Abstract

Mitogen‑activated protein kinase‑activated protein kinase 2 (MK2) and its mediated inflammation are involved in various diseases, including spinal cord injury (SCI). Ultrashortwave (USW) radiation has previously been reported to exert a protective effect on SCI. In the present study, through a series of reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), western blot and immunofluorescence assay, it was found that MK2 and tumor necrosis factor (TNF)‑α/interleukin (IL)‑1β were elevated in patients with SCI and in H2O2‑treated C8‑D1A cells. Through gene level and protein level detection by using of RT‑qPCR, western blot, immunofluorescence assay and terminal deoxynucleotidyl transferase (TdT) dUTP nick‑end labeling assay, it was demonstrated that USW radiation inhibited the expression of MK2/TNF‑α/IL‑1β and suppressed the apoptosis of H2O2‑treated C8‑D1A cells. Furthermore, it was confirmed that the overexpression of MK2 reversed the protective effect of USW on C8‑D1A cells, which indicated that USW achieved its function via regulation of the MK2/TNF‑α/IL‑1β pathway. Finally, using a constructed in vivo model and a series of RT‑qPCR, western blot and IHC detection, it was confirmed that USW suppressed the expression of MK2 to promote functional recovery following SCI.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30066830      PMCID: PMC6108855          DOI: 10.3892/ijmm.2018.3786

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


Introduction

Traumatic spinal cord injury (SCI) is a problematic disease that results in a substantial burden on human society, and has a marked effect on the mind and body of patients (1,2). In general, the pathological process of SCI is divided into two stages: The acute phase and subacute phase, in which secondary damage to central nervous system (CNS) tissue occurs due to a variety of factors, including ischemia, hemorrhage, excitotoxic damage and inflammation (3). It is widely accepted that innumerable cytokines and signaling pathways mediating the inflammatory response contribute to the secondary damage following SCI (4-7). Mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) has been reported as a direct substrate of p38α and p38β MAPKs, and is a novel molecular target for the anti-inflammatory response (8). Based on an animal study of Parkinson's disease, Gómez-Nicola found that MK2-knockout mice exhibited reduced neurotoxicity and reduced neuroinflammation (9). In addition, Tietz et al revealed that MK2 is key in the regulation and limitation of the immune response in the CNS (10). To date, there have been few studies on MK2 and SCI. Ghasemlou et al reported that a lack of MK2 contributed to a reduction in tissue damage following SCI and an improvement in locomotor recovery (11). In our previous study, it was found that bone marrow stromal cell (BMSC) transplantation combined with exposure to USW (USW) radiation promoted tissue repair and functional recovery following SCI. It was also demonstrated that the transplantation of BMSCs combined with exposure to USW radiation inhibited ED1, a marker of activated macrophages, and the expression of glial fibrillary acidic protein, which indicated a weakening of the inflammatory response (12). In another previous study, it was found that USW therapy promotes nerve axon regeneration and Schwann cell proliferation (13). The present study focused on the effect of USW radiation on astrocyte inflammation. Using H2O2-treated astrocyte SCI cell models and construction of an SCI rat model, it was revealed that USW radiation inhibited the MK2-mediated inflammatory response and promoted the repair of SCI. The findings of the present study provide an improved understanding of USW radiation in the treatment of SCI.

Materials and methods

Patients and tissue samples

Serum specimens from 20 cases of patients with acute SCI and paired serum specimens from 20 cases without SCI were collected at Shengjing Hospital of China Medical University (Shenyang, China) between January 2016 and December 2016. All cases were diagnosed according to the American Spinal Injury Association (ASIA; 2011) (14). Written informed consent was obtained from the patients whose serum specimens were used in the present study. The Institute Research Medical Ethics Committee of Shengjing Hospital of China Medical University granted approval for the study.

Astrocyte culture

C8-D1A murine astrocytes (cat. no. CRL-2541) were purchased from America Type Culture Collection (Manassas, VA, USA. The culture medium consisted of Dulbecco's Modified Eagle's Medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% (v/v) fetal bovine serum (Invitrogen; Thermo Fisher Scientific, Inc.), 100 IU/ml penicillin and 100 mg/ml streptomycin (Baomanbio, Shanghai, China). All C8-D1A cells were maintained at 37°C in a humidified atmosphere containing 5% CO2. The culture medium was replaced every third day. Cells were passaged with a ratio of 1:4 when growing to 80% confluence.

H2O2 intervention and USW radiation exposure

For the H2O2 intervention, 200 µM H2O2 was added to different groups of C8-D1A cells (5×105) for 12 h, according to a previous study (14), and these were then harvested for subsequent detection. For the USW radiation exposure, a USW device (Shanghai Electrical Device Company, Shanghai, China) was used for USW radiation exposure at a frequency of 40.68 MHz, with a maximum and actual export power of 11.32 W.

Plasmid construction and transfection

The full length MK2 was amplified and cloned into the KpnI and XhoI restriction sites (Promega Corporation, Madison, WI, USA) of the pcDNA3.1 vector (Invitrogen; Thermo Fisher Scientific, Inc.) to synthetize an MK2-overexpression plasmid (pcDNA3.1-MK2). The pcDNA3.1-MK2 plasmids were transfected into the cultured C8-D1A cells in the presence of H2O2 to construct the MK2-overexpression SCI cell model by using of Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). The pcDNA3.1 vector was transfected into cells in the control SCI cell model. Total RNAs and total proteins were harvested 24 h following transfection for further detection.

Immunofluorescence analysis

The immunofluorescence procedure was performed as previously reported (15). Briefly, the C8-D1A cells (5×105) were passaged onto glass coverslips (0.8×0.8 cm) and cultured to 50-60% confluence. Following rinsing twice with PBS, the coverslips were fixed with 4% paraformaldehyde for 15 min and blocked with 5% BSA (Cell Signaling Technologies, Inc., Danvers, MA, USA) for 1 h at room temperature. Subsequently, rabbit anti-MK2 antibody (Abcam, Cambridge, UK; 1:100; cat. no. ab131504) was added for incubation at 4°C overnight. The following day, following incubation with fluorescent secondary antibodies (1:200; cat. no. ab150081, Abcam) at room temperature for 1 h, the coverslips were observed under a fluorescent microscope (Leica Microsystems GmbH, Wetzlar, Germany). Images were captured and analyzed using Image-Pro Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

All the procedures were performed as described previously (16). In brief, total RNA was extracted using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. cDNA was synthesized using the PrimeScript RT Reagent kit (Takara Biotechnology Co., Ltd., Dalian, China). The RT-qPCR analysis was performed using SYBR-Green Premix Ex Taq (Takara Biotechnology Co., Ltd.) on Light Cycler 480 system (Roche Diagnostics, Basel, Switzerland) according to the manufacturer's protocol. The expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and MK2 were calculated using β-actin as an internal control by the 2−ΔΔCq method (17). The primers used in the present study were as follows: TNF-α, forward 5′-CCA CGT CGT AGC AGC AAA CCA CCA AG-3′ and reverse 5′-CAG GTA CAT GGG CTC CTC ATA CC-3′; IL-1β, forward 5′-CCC AAC TGG TAC ATC AGC ACC TC-3′ and reverse 5′-GAC ACG GAT TCC ATG GTG AAG TC-3′; MK2, forward 5′-GAC ATG TGG TCC TTG GGT GTC ATC ATG-3′ and reverse 5′-GAG ATG GCA AGG CCG TGA TTG GAA TAG-3′; β-actin, forward 5′-AGT GTG ACG TGG ACA TCC GCA AAG-3′ and reverse 5′-ATC CAC ATC TGC TGG AAG GTG GAC-3′. The thermocycling conditions were: Pre-denaturation at 95°C for 15 sec, followed by a denaturation at 95°C for 5 sec, annealing and extension at 60°C for 30 sec for 45 cycles.

Western blot analysis

Total protein from the cells and tissue specimens were extracted using RIPA lysis buffer (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Protein concentration was quantified using the BCA protein assay kit (Santa Cruz Biotechnology, Inc.) A total of 40 µg proteins were subjected to 10% SDS-PAGE and transferred onto a PVDF membrane, and then blocked by 5% BSA (Cell Signaling Technologies, Inc.) for 1 h at room temperature. Each membrane was incubated with primary antibodies at 4°C overnight, followed by incubation with secondary antibodies [goat anti-rabbit IgG horseradish peroxidase (HRP), 1:2,000; cat. no. ab205718; Abcam] at room temperature for 1 h the following day. The following antibodies were used: Rabbit anti-MK2 antibody (1:500); rabbit anti-TNF-α antibody (1:500; ab6671; Abcam) and rabbit anti-GAPDH antibody (1:10,000; ab128915; Abcam). After three washes with TBST, an ECL Western Blotting Substrate Kit (cat. no. ab65623; Abcam) was applied for chemiluminescence imaging by using of Image J2X software (Rawak Software Inc., Stuttgart, Germany).

Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay

Cell apoptosis was determined using a TUNEL assay, as previously described (18). Briefly, the C8-D1A cells were seeded on coverslips and were then fixed using 4% paraformaldehyde for 30 min, followed by permeabilizing with 0.1% Triton X-100 for 2 min on ice. The cells were then labeled using a TUNEL kit (Nanjing Keygen Biotech Co., Ltd., Nanjing, China) according to the manufacturer's protocol. The apoptotic index was calculated using the following formula: Apoptotic index = (total number of apoptotic cells/total number of cells) × 100%.

Establishment of animal models and Basso-Beattie-Bresnahan (BBB) evaluation

All the procedures were performed as previously reported (12). A total of 48 Sprague-Dawley female rats (average weight: 180-220 g) with an average age of 12-weeks-old, provided by the Experimental Animal Center at Shengjing Hospital of China Medical University, were randomly divided into three groups (n=16 each): Sham-operated group, control group (SCI animals) and USW group (SCI animals exposed to USW radiation). All animals were housed in a condition of 20-25°C with 6-80% humidity and all animals were maintained under a 12 h light/dark cycle with free access to food and water. Spinal cord contusion was inflicted using Allen's method (Allen, 1911) when the animals were under intraperitoneal anesthesia (12). A 2-cm midline incision was made over the T9-T11 spinal region, and the soft tissue and T9-T11 vertebrae were removed. Laminectomy was performed at the T10 level under a surgical microscope, avoiding dura matter laceration. The spinal cord was injured using a modified Allen's impactor, where a guided 9-g rod was dropped 10 cm onto the exposed dura mater, representing moderate SCI. Following recovery from anesthesia, the rats exhibited paralysis of both hind limbs, urine and stool disorder, mental weakness, and slow and poor feeding, and received manual bladder expression twice daily until recovery of sphincter control. For the postoperative treatment of animals in the USW group, a pair of disc electrodes 4 cm in diameter was placed bilaterally on the T9-T11 vertebrae at a distance of 2 cm from the skin. The USW device (Shanghai Electrical Device Company) was operated at a frequency of 40.68 MHz, with maximum and actual export powers of 40 and 11.32 W, respectively. USW treatment was executed daily with a radiating exposure of 7 min/time until the animals were sacrificed.

A 21-point BBB scale was used to assess the hind limb locomotor function (19)

The tests were performed prior to surgery and at 1-week intervals following SCI for 4 weeks. The animals were placed individually on an open field (radius, 90 cm) and allowed to move freely for 4 min. Performance was evaluated by two experienced observers blinded to the treatment groups.

Immunohistochemistry

All the procedures were performed as described previously (20). In brief, tissue slides (4-µm thick) were incubated with a TNF-α/MK2 primary antibody at 4°C overnight, and subsequently incubated with biotinylated secondary antibodies (2 µg/ml; Abcam) at 37°C for 30 min. This was followed by streptavidin-HRP complex incubation and diaminobenzidine tetrahydrochloride (Abcam) staining, and hematoxylin (Abcam) counterstaining. All slides were assessed independently under a Leica DMILLED inverted microscope (Olympus Corporation, Tokyo, Japan) by two experienced pathologists, who were blinded to patient clinical pathology and other information. The expression level of TNF-α/MK2 was evaluated as described previously (21).

Statistical analysis

All data are presented as the mean ± standard deviation and were analyzed using GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference. Two-way analysis of variance was used to compare groups (between-subject) and time following surgery (within-subject and repeated measures), and one-way analysis of variance was used to examine differences in the between-subject factor. A post hoc Bonferroni test was used when necessary to examine specific differences between groups.

Results

MK2 is elevated in patients with SCI and H2O2-treated C8-D1A cells

The expression of MK2 was detected in serum specimens of 20 patients with SCI and in paired serum specimens of 20 patients without SCI. As shown in Fig. 1A and B, the expression of MK2 was elevated in serum specimens of patients with SCI, compared with that in serum specimens of patients without SCI (P<0.01). Secondly, H2O2 was used to simulate an astrocyte inflammation cell model. As shown in Fig. 1C and D, the expression levels of TNF-α and IL-1β, two common markers of inflammation, were significantly increased in the H2O2-treated C8-D1A cells, compared with those in the control group (P<0.01). Thirdly, the expression of MK2 was measured at the cellular level. As shown in Fig. 1E–G, the expression of MK2 was also elevated in the H2O2-treated C8-D1A cells (P<0.01). All the above findings indicated that an elevated level MK2 was present in patients with SCI and in the H2O2-treated astrocyte cell model.
Figure 1

MK2 is elevated in patients with SCI and H2O2-treated C8-D1A cells. MK2 was elevated in patients with SCI, compared with non SCI group as determined by (A) RT-qPCR and (B) western blot analyses. **P<0.01, vs. non SCI group. Expression levels of TNF-α and IL-1β were also elevated in the patients with SCI, compared with the non SCI group, as determined by (C) RT-qPCR and (D) western blot analyses. **P<0.01, vs. non SCI group. MK2 was upregulated in H2O2-treated C8-D1A cells, compared with the control group, as detected by (E) RT-qPCR, (F) western blot and (G) immunofluorescence analyses (magnification, ×200; scale bar=100 µm). **P<0.01, vs. control group. SCI, spinal cord injury; MK2, mitogen-activated protein kinase-activated protein kinase 2; IL interleukin; TNF-α, tumor necrosis factor-α; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.

USW radiation inhibits the inflammatory response and apoptosis in C8-D1A cells

In our previous study, it was found that USW therapy combined with BMSC transplantation promoted the functional recovery of SCI in rats (12). Therefore, the present study examined whether USW radiation was able to alleviate the astrocyte inflammatory response following SCI at the cellular level. The expression levels of TNF-α and IL-1β were detected in each group. As shown in Fig. 2A and B, compared with the control group, the expression levels of TNF-α and IL-1β in the H2O2 group and H2O2 + USW group were elevated (P<0.01). Compared with the H2O2 group, the expression levels of TNF-α and IL-1β in the H2O2 + USW group were significantly decreased (P<0.05). These results indicated that USW radiation alleviated the inflammatory response of the astrocytes following USW exposure. In addition, the expression of MK2 was measured in the above-mentioned cell models. As shown in Fig. 2C and D, USW radiation inhibited the expression of MK2 in the H2O2-treated C8-D1A cells (P<0.05). Furthermore, the effect of USW treatment on the apoptosis of C8-D1A cells was determined using a TUNEL assay. As shown in Fig. 2E, USW treatment inhibited cell apoptosis in the H2O2-treated C8-D1A cells (P<0.01). The above results supported the hypothesis that USW radiation alleviates the inflammatory response and apoptosis following H2O2 intervention, and it was revealed that USW radiation had a protective effect in astrocytes following H2O2 intervention.
Figure 2

USW radiation inhibits the inflammatory response and apoptosis in C8-D1A cells. USW radiation inhibited the expression of TNF-α and IL-1β in H2O2-treated C8-D1A cells, compared with the control group, as detected by (A) RT-qPCR and (B) western blot analyses. **P<0.01 vs. control group; #P<0.05, vs. H2O2 group. USW radiation inhibited the expression of MK2 in H2O2-treated C8-D1A cells, compared with the control group, as detected by (C) western blot and (D) RT-qPCR analyses. **P<0.01, vs. control group; #P<0.05, vs. H2O2 group. (E) USW radiation inhibited apoptosis of H2O2-treated C8-D1A cells, compared with the control group, as determined using a TUNEL assay (magnification, ×400; scale bar=75 µm). **P<0.01, vs. control group; ##P<0.05, vs. H2O2 group. USW, ultrashortwave; MK2, mitogen-activated protein kinase-activated protein kinase 2; IL interleukin; TNF-α, tumor necrosis factor-α; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; TUNEL, terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling.

Upregulation of MK2 reverses the protective effect USW radiation on C8-D1A cells

As described above, it was found that USW radiation alleviated the inflammatory response and inhibited the expression of MK2 in H2O2-treated C8-D1A cells. Therefore, whether the protective effect of USW radiation on the inflammatory response was achieved through the MK2 pathway was investigated. An MK2-overexpression plasmid (pcDNA3.1-MK2) was constructed, and the constructed pcDNA3.1-MK2 plasmid was then transfected into the USW radiation-treated C8-D1A cells. As shown in Fig. 3A–C, transfection of the cells with pcDNA3.1-MK2 led to a significant elevation in the expression of MK2 in the USW radiation-treated C8-D1A cells (P<0.01). It was also confirmed that the elevation of MK2 promoted the expression of TNF-α and IL-1β with the presence of USW radiation (Fig. 3D–G; P<0.01). In addition, the results revealed that the overexpression of MK2 promoted C8-D1A cell apoptosis in the presence of USW radiation (Fig. 3H; P<0.01). Therefore, the findings revealed that the upregulation of MK2 reversed the protective effect USW radiation on the C8-D1A cells.
Figure 3

Upregulation of MK2 reverses the protective effect USW radiation on C8-D1A cells. Expression of MK2 in USW radiation-treated C8-D1A cells was elevated by transfection with pcDNA3.1-MK2, as detected by (A) RT-qPCR, (B) western blot and (C) immunofluorescence analyses (Magnification, ×200; scale bar=100 µm). **P<0.01, vs. H2O2 + USW + pcDNA3.1 group. Elevation of MK2 reversed the inhibitory effect USW radiation on TNF-α, as determined by (D) RT-qPCR and (E) western blot analyses, and on IL-1β, as determined by (F) RT-qPCR and (G) western blot analyses. **P<0.01, vs. H2O2 + USW + pcDNA3.1 group. (H) Overexpression of MK2 attenuated the suppressive effect USW radiation on apoptosis, as detected using a TUNEL assay (magnification, ×400; scale bar=75 µm). **P<0.01, vs. H2O2 + USW + pcDNA3.1 group. USW, ultrashortwave; MK2, mitogen-activated protein kinase-activated protein kinase 2; IL interleukin; TNF-α, tumor necrosis factor-α; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; TUNEL, terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling.

USW suppresses the expression of MK2 and promotes functional recovery following SCI in vivo

To further confirm the protective effect of USW radiation on SCI in vivo, an SCI rat model was constructed as previously reported (12). USW radiation was applied in treating the rats in the USW group (Fig. 4A). As shown in Fig. 4B, compared with the sham surgery group, the average BBB scores of the control group and USW group were markedly decreased, indicating that the animal model was successfully constructed. When comparing the differences between the control group and USW group, it was found that the BBB scores in the USW group were prominently higher than those in the control group (Fig. 4B). These results demonstrated that USW promoted the functional recovery of SCI. The expression level of TNF-α was then determined in each group by IHC, RT-qPCR and western blot analyses. As shown in Fig. 4C and D, compared with the control group, USW radiation treatment markedly inhibited the expression of TNF-α and IL-1β. The expression of MK2 was determined using the same methods and, as shown in Fig. 4F, USW radiation markedly suppressed the expression of MK2 in vivo. Finally, apoptosis in the animal model was determined. As shown in Fig. 4F, USW radiation significantly inhibited apoptosis in the SCI rats.
Figure 4

USW radiation suppresses the expression of MK2 and promotes functional recovery following SCI in rats. (A) Construction of SCI models using (a1) Allen's methods and (a2) USW treatment. (B) BBB score system was applied to evaluate the changes in locomotor function following USW radiation intervention. *P<0.05 and **P<0.01, vs. control group. USW radiation inhibited the expression of (C) TNF-α and (D) IL-1β in vivo, as determined by IHC (magnification, ×100; scale bar=200 µm), western blot and a RT-qPCR analyses. *P<0.05 and **P<0.01, vs. sham surgery group; ##P<0.01, vs. control group. (E) Expression of MK2 was decreased by USW radiation in vivo, as determined by IHC (magnification, ×100; scale bar, 200 µm), western blot and RT-qPCR analyses. *P<0.05 and **P<0.01, vs. sham surgery group; ##P<0.01, vs. control group. (F) USW radiation suppressed apoptosis following SCI, as measured using IHC (magnification, ×400; scale bar=50 µm). **P<0.01, vs. sham surgery group; ##P<0.01, vs. control group. USW, ultrashortwave; MK2, mitogen-activated protein kinase-activated protein kinase 2; IL interleukin; TNF-α, tumor necrosis factor-α; BBB, Basso-Beattie-Bresnahan; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.

In brief, as the mechanism in Fig. 5 shows, the results described above confirmed that USW radiation promoted SCI recovery by inhibiting inflammation via suppression of the MK2/TNF-α pathway.
Figure 5

Schematic diagram of the proposed mechanism of the effect of ultrashortwave radiation on spinal cord injury. MK2, mitogen-activated protein kinase-activated protein kinase 2; TNF-α, tumor necrosis factor-α.

Discussion

Inflammation is an essential defense mechanism, which is vital in protecting against various pathogenic attacks, including SCI (3,22,23). As a downstream substrate of p38 MAPKs and a novel molecular target of the anti-inflammatory response, MK2 is located at human chromosome 1q32.1 and functions as a key regulator in the treatment of inflammatory diseases, particularly in nervous system inflammation (8,24). Ghasemlou et al reported that a lack of MK2 promoted loco-motor recovery and reduced tissue damage following SCI (11). Kroner et al reported that MK2 facilitated TNF-induced M1 macrophage polarization following SCI (25). The present study focused on the expression and function of MK2 following SCI. It was found that the expression of MK2 was elevated in patients with SCI and in an H2O2-treated astrocyte cell model, which confirmed the role of MK2 as an inflammatory factor in SCI, as previously reported. In addition, through a constructed MK2-overexpression plasmid, the present study demonstrated that the elevation of MK2 reversed the protective effect of USW radiation on C8-D1A cells via promotion of the expression of TNF-α and IL-1β. As a downstream gene of MK2, TNF-α and IL-1β are known markers of various inflammatory conditions (26,27). Tietz et al reported that TNF-α and IL-6 signaling were mediated by the MK2 pathway, and that the knockdown of MK2 inhibited the expression of TNF-α/IL-6 and protected against cerulein-induced pancreatitis (28). In the present study, TNF-α and IL-1β were selected as molecular markers in SCI-related inflammation. The cellular and animal experiments confirmed that TNF-α and IL-1β were elevated following the different inflammation-related interventions. Of note, it was revealed again that the up-regulation of MK2 led to elevated expression levels of TNF-α and IL-1β, indicating that MK2 was upstream of these genes. As a type of high frequency electric field, USW radiation exerts its function via a mechanism of heating and non-heating effects. A low field intensity of electric field (40 mW/cm2) caused by a small dose of USW radiation may lead to full extension or contraction on cells and may result in biological effects via specific stimulation on cells or tissues. Pelletier et al reported that the direct exposure to current electric field stimulation resulted in morphological and molecular changes of brain cells (29). In the present study, it was confirmed that USW radiation alleviated the inflammatory response in H2O2-treated C8-D1A cells. In addition, it was confirmed that USW inhibited H2O2-induced apoptosis in C8-D1A cells. Furthermore, through in vivo experiments, the present study also demonstrated the protective effect of USW radiation on the constructed SCI rat model. In terms of the molecular mechanism, it was shown that USW radiation suppressed the expression of MK2 in the in vivo and in vitro experiments. The inflammatory response of SCI and its treatment are complex issues. The findings of the present study revealed that USW promoted SCI recovery and alleviation of the inflammatory response following SCI via the suppression of MK2; however, the detailed mechanism of this effect on MK2 occurs remains to be fully elucidated. The results of the present study may provide a novel target in the molecular treatment of SCI.
  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MK2: a novel molecular target for anti-inflammatory therapy.

Authors:  Senthil Duraisamy; Malini Bajpai; Usha Bughani; Sunanda G Dastidar; Abhijit Ray; Puneet Chopra
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

Review 3.  Inflammatory pathways in spinal cord injury.

Authors:  Samuel David; Juan Guillermo Zarruk; Nader Ghasemlou
Journal:  Int Rev Neurobiol       Date:  2012       Impact factor: 3.230

4.  Gene deletion of MK2 inhibits TNF-alpha and IL-6 and protects against cerulein-induced pancreatitis.

Authors:  Anne Barbara Tietz; Antje Malo; Joachim Diebold; Alexey Kotlyarov; Andreas Herbst; Frank T Kolligs; Barbara Brandt-Nedelev; Walter Halangk; Matthias Gaestel; Burkhard Göke; Claus Schäfer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-19       Impact factor: 4.052

Review 5.  TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.

Authors:  Lisa M Sedger; Michael F McDermott
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-01       Impact factor: 7.638

6.  The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.

Authors:  Simon J Pelletier; Marie Lagacé; Isabelle St-Amour; Dany Arsenault; Giulia Cisbani; Audrey Chabrat; Shirley Fecteau; Martin Lévesque; Francesca Cicchetti
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

7.  Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells.

Authors:  Yong Wang; Yueyang Zhang; Tao Yang; Wei Zhao; Ningning Wang; Pengcheng Li; Xiandong Zeng; Weiguo Zhang
Journal:  Oncotarget       Date:  2017-07-31

8.  Decrease of miR-195 Promotes Chondrocytes Proliferation and Maintenance of Chondrogenic Phenotype via Targeting FGF-18 Pathway.

Authors:  Yong Wang; Tao Yang; Yadong Liu; Wei Zhao; Zhen Zhang; Ming Lu; Weiguo Zhang
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

9.  Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells.

Authors:  Yong Wang; Jie Sun; Xilin Wei; Lan Luan; Xiandong Zeng; Cuifang Wang; Wei Zhao
Journal:  Onco Targets Ther       Date:  2017-02-22       Impact factor: 4.147

Review 10.  Managing inflammation after spinal cord injury through manipulation of macrophage function.

Authors:  Yi Ren; Wise Young
Journal:  Neural Plast       Date:  2013-10-31       Impact factor: 3.599

View more
  2 in total

1.  Revealing Potential Spinal Cord Injury Biomarkers and Immune Cell Infiltration Characteristics in Mice.

Authors:  Liang Cao; Qing Li
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

2.  Anti-Inflammatory and Anti-Oxidant Activity of Ultra-Short Wave Diathermy on LPS-Induced Rat Lung Injury.

Authors:  Q Wu; M Qu; P Zhong; Y Zeng; J Wang; Q Zhang; Ting Wang; D Liu; L Yang; J Zhou; Tong Wang
Journal:  Bull Exp Biol Med       Date:  2022-02-17       Impact factor: 0.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.